Tamoxifen and risk of contralateral breast cancer in BRCA1...

The Lancet 2000 Vol. 356; Iss. 9245

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

Steven A Narod, Jean-Sébastien Brunet, Parviz Ghadirian, Mark Robson, Ketil Heimdal, Susan L Neuhausen, Dominique Stoppa-Lyonnet, Caryn Lerman, Barbara Pasini, Patricia de los Rios, Barbara Weber, Hen
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
356
Year:
2000
Language:
english
DOI:
10.1016/s0140-6736(00)03258-x
File:
PDF, 98 KB
english, 2000
Conversion to is in progress
Conversion to is failed